Infection Prevention and Control Market Impacted By Increase In HIAS

Posted by IndustryARC on May 29th, 2019

A subtle increase has been observed in hospital-acquired infections (HIAS) in many countries of the world. Being a storehouse for different kinds of pathogens, bacteria, and viruses, hospitals and clinics are often responsible for incessant spreading of certain communicable diseases. The Centre for Disease Control and Prevention has assessed that around 2 million patients every year experience the ill-effects of infections acquired by contaminated hospital environments annually according to business intelligence report published by IndustryARC. According to the report, the infection prevention and control market will expand with a CAGR of 5.3% during the forecast period 2018-2023.

The IndustryARC report is titled ‘Infection prevention & Control Market: By Infections (Microbial & Others); By Antimicrobial Drugs (Antibacterial & Others); By Accessories & Equipment (Disinfectants & Others); By End User (Equipment & Drug Usage) & By Geography - Forecast (2018-2023).’ The analyst of the report has worked on the report using statistical information related to hand sanitizer market, healthcare industry, and presented detailed information regarding how the market will grow in the upcoming years.

Infection Prevention and Control Market: Regional Analysis

According to the analyst of the report, the global infection prevention and control market is being led by North America. The revenue earned by this market in North American region is set to rise with a CAGR of 4.3% throughout the forecast period. This is highly credited to the growing efforts made by the Centre for Disease Control and Prevention who have started numerous initiatives which stress on the importance of preventing one’s self from pathogens in hospital atmosphere. Another factor adding to this is the increase of end-user products in the general population owing to rising globalization and increase in disposable income.

View Full Table Of Contents @ https://industryarc.com/Report/1309/Infection-Prevention-and-Control-Market-analysis-report.html

Infection Prevention and Control Market: Growth Drivers

• Increase in Number of Surgical Procedures

According to Managaram, a member of the Hospital Infection Control Practices Advisory Committee, surgical infections are extremely prominent in the exposed areas during surgical procedures. These infections have a probability of manifesting within 30 days and can even lead to amputation.

• Aging Population

With first world countries housing a number of immigrants, aging population has become common and governments are taking several initiatives to increase awareness amongst them regarding prevention of infectious diseases.

Infection Prevention and Control Market: Competitive Landscape

The growth of this market depends on how well the key companies advertise their products and ensure that they reach the common citizens. These key market players include Abbott Laboratories, Alere Inc., Ansell Limited, Astrazeneca PLC, Bard Incorporated, Becton, Dickinson and Company, Belimed, Cantel Medical Corp, Covidien, Getinge Group, Hollister Incorporated, Johnson & Johnson, Kimberly Clark, Merck & Co., Pfizer Inc., Roche, Siemens Healthcare Diagnostics Inc., Supermax Corporation Berhad, Terumo Corporation, and the 3M Company.

What can you expect from the report?

The Infection Prevention and Control Market is Prepared with the Main Agenda to Cover the following 20 points:

1. Infection Prevention and Control Market Size by Product Categories & Application

2. Infection Prevention and Control Market trends & Relevant Market Data

3. Manufacturer Landscape

4. Distributor Landscape

5. Pricing Analysis

6. Top 10 End-user Analysis

7. Product Benchmarking

8. Product Developments

9. Mergers & Acquisition Analysis

10. Patent Analysis

11. Infection Prevention and Control Market Demand Analysis (Revenue & Volume)

12. Country-level Analysis

13. Competitor Analysis

14. Infection Prevention and Control Market Shares Analysis

15. Value Chain Analysis

16. Supply Chain Analysis

17. Infection Prevention and Control Market Strategic Analysis

18. Infection Prevention and Control Market Current & Future Market Landscape Analysis

19. Opportunity Analysis

20. Infection Prevention and Control Market Revenue and Volume Analysis

Frequently Asked Questions:

Q. Does IndustryARC provide customized reports and charge additionally for limited customization?

Response: Yes, we can customize the report by extracting data from our database of reports and annual subscription databases. We can provide the following free customization:

1. Increase the level of data in application or end user industry.

2. Increase the number of countries in geography chapter.

3. Find out market shares for other smaller companies or companies which are of interest to you.

4. Company profiles can be requested based on your interest.

5. Patent analysis, pricing, product analysis, product benchmarking, value and supply chain analysis can be requested for a country or end use segment.

Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com  to discuss more about our consulting services.

Media Contact:

Mr. Venkat Reddy

Sales Manager

Email : sales@industryarc.com

Contact Sales: +1-614-588-8538 (Ext-101)

About IndustryARC: IndustryARC is a research and consulting firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food and Beverages, Information Technology, and Life Sciences and Healthcare.